REGENXBIO Inc.
USD6.52
-0.62 (-8.68%)
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.07
Prev. Close
$7.14
Day Low
$6.44
Day High
$7.09
52W Low
$5.46
52W High
$16.19
Market Cap
$0.34B
Volume
1.19M
| 5,124 |
| $10.35 |
| 3 Feb 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | F-InKind | Disposed | 4,700 | $11.16 |
| 3 Feb 2026 | PAKOLA STEVE | Chief Medical Officer | F-InKind | Disposed | 5,267 | $11.16 |
| 29 Jan 2026 | Mills Kenneth T. | director | F-InKind | Disposed | 221,753 | $13.41 |
| 29 Jan 2026 | Mills Kenneth T. | director | M-Exempt | Acquired | 225,000 | $13.09 |
| 29 Jan 2026 | Mills Kenneth T. | director | M-Exempt | Disposed | 225,000 | $13.09 |
| 8 Jan 2026 | PAKOLA STEVE | Chief Medical Officer | A-Award | Acquired | 65,847 | $0.00 |
| 8 Jan 2026 | PAKOLA STEVE | Chief Medical Officer | A-Award | Acquired | 35,402 | $14.18 |
| 8 Jan 2026 | Malzahn Craig | Chief Technology Officer | A-Award | Acquired | 65,847 | $0.00 |